These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 22427774)

  • 21. Upregulation of RANTES in psoriatic keratinocytes: a possible pathogenic mechanism for psoriasis.
    Raychaudhuri SP; Jiang WY; Farber EM; Schall TJ; Ruff MR; Pert CB
    Acta Derm Venereol; 1999 Jan; 79(1):9-11. PubMed ID: 10086850
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of IL-20 in synovium and lesional skin of patients with psoriatic arthritis: differential response to alefacept treatment.
    Lebre MC; Jonckheere CL; Kraan MC; van Kuijk AW; Bos JD; de Rie M; Gerlag DM; Tak PP
    Arthritis Res Ther; 2012 Sep; 14(5):R200. PubMed ID: 23006144
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interleukin-6 in the epidermis of patients with psoriasis before and during PUVA treatment.
    Oxholm A; Oxholm P; Staberg B; Bendtzen K
    Acta Derm Venereol; 1989; 69(3):195-9. PubMed ID: 2566221
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GRO-alpha mRNA is selectively overexpressed in psoriatic epidermis and is reduced by cyclosporin A in vivo, but not in cultured keratinocytes.
    Kojima T; Cromie MA; Fisher GJ; Voorhees JJ; Elder JT
    J Invest Dermatol; 1993 Dec; 101(6):767-72. PubMed ID: 8245503
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA-181b negatively regulates the proliferation of human epidermal keratinocytes in psoriasis through targeting TLR4.
    Feng C; Bai M; Yu NZ; Wang XJ; Liu Z
    J Cell Mol Med; 2017 Feb; 21(2):278-285. PubMed ID: 27641447
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interleukin-13 receptor in psoriatic keratinocytes: overexpression of the mRNA and underexpression of the protein.
    Cancino-Díaz JC; Reyes-Maldonado E; Bañuelos-Pánuco CA; Jiménez-Zamudio L; García-Latorre E; León-Dorantes G; Blancas-González F; Paredes-Cabrera G; Cancino-Díaz ME
    J Invest Dermatol; 2002 Nov; 119(5):1114-20. PubMed ID: 12445201
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Topical retinoic acid alters the expression of cellular retinoic acid-binding protein-I and cellular retinoic acid-binding protein-II in non-lesional but not lesional psoriatic skin.
    Karlsson T; Virtanen M; Sirsjö A; Rollman O; Vahlquist A; Törmä H
    Exp Dermatol; 2002 Apr; 11(2):143-52. PubMed ID: 11994141
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The cytokine network in lesional and lesion-free psoriatic skin is characterized by a T-helper type 1 cell-mediated response.
    Uyemura K; Yamamura M; Fivenson DF; Modlin RL; Nickoloff BJ
    J Invest Dermatol; 1993 Nov; 101(5):701-5. PubMed ID: 7693825
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IL-1 activity is reduced in psoriatic skin. Decreased IL-1 alpha and increased nonfunctional IL-1 beta.
    Cooper KD; Hammerberg C; Baadsgaard O; Elder JT; Chan LS; Sauder DN; Voorhees JJ; Fisher G
    J Immunol; 1990 Jun; 144(12):4593-603. PubMed ID: 2191038
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IL-10 levels are decreased in psoriatic lesional skin as compared to the psoriatic lesion-free and normal skin suction blister fluids.
    Mussi A; Bonifati C; Carducci M; Viola M; Tomaselli R; Sacerdoti G; Fazio M; Ameglio F
    J Biol Regul Homeost Agents; 1994; 8(4):117-20. PubMed ID: 7660853
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interleukin-11 production is increased in organ cultures of lesional skin of patients with active plaque-type psoriasis as compared with nonlesional and normal skin. Similarity to interleukin-1 beta, interleukin-6 and interleukin-8.
    Ameglio F; Bonifati C; Fazio M; Mussi A; Trento E; Cordial Fei P; Donati P; Pimpinelli F; D'Auria L; Carducci M
    Arch Dermatol Res; 1997 Jun; 289(7):399-403. PubMed ID: 9248618
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of IL-20 and its receptors on psoriatic skin.
    Wei CC; Chen WY; Wang YC; Chen PJ; Lee JY; Wong TW; Chen WC; Wu JC; Chen GY; Chang MS; Lin YC
    Clin Immunol; 2005 Oct; 117(1):65-72. PubMed ID: 16043414
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Galectin-7 downregulation in lesional keratinocytes contributes to enhanced IL-17A signaling and skin pathology in psoriasis.
    Chen HL; Lo CH; Huang CC; Lu MP; Hu PY; Chen CS; Chueh DY; Chen P; Lin TN; Lo YH; Hsiao YP; Hsu DK; Liu FT
    J Clin Invest; 2021 Jan; 131(1):. PubMed ID: 33055419
    [TBL] [Abstract][Full Text] [Related]  

  • 34. β-Defensin 2 is a responsive biomarker of IL-17A-driven skin pathology in patients with psoriasis.
    Kolbinger F; Loesche C; Valentin MA; Jiang X; Cheng Y; Jarvis P; Peters T; Calonder C; Bruin G; Polus F; Aigner B; Lee DM; Bodenlenz M; Sinner F; Pieber TR; Patel DD
    J Allergy Clin Immunol; 2017 Mar; 139(3):923-932.e8. PubMed ID: 27502297
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spontaneous release of leukemia inhibitory factor and oncostatin-M is increased in supernatants of short-term organ cultures from lesional psoriatic skin.
    Bonifati C; Mussi A; D'Auria L; Carducci M; Trento E; Cordiali-Fei P; Ameglio F
    Arch Dermatol Res; 1998; 290(1-2):9-13. PubMed ID: 9522995
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevated leukaemia inhibitory factor (LIF) expression in lesional psoriatic skin: correlation with interleukin (IL)-8 expression.
    Szepietowski J; Walker C; Hunter JA; McKenzie RC
    J Dermatol; 2001 Mar; 28(3):115-22. PubMed ID: 11349461
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kinetics and regulation of human keratinocyte stem cell growth in short-term primary ex vivo culture. Cooperative growth factors from psoriatic lesional T lymphocytes stimulate proliferation among psoriatic uninvolved, but not normal, stem keratinocytes.
    Bata-Csorgo Z; Hammerberg C; Voorhees JJ; Cooper KD
    J Clin Invest; 1995 Jan; 95(1):317-27. PubMed ID: 7529261
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes.
    Grossman RM; Krueger J; Yourish D; Granelli-Piperno A; Murphy DP; May LT; Kupper TS; Sehgal PB; Gottlieb AB
    Proc Natl Acad Sci U S A; 1989 Aug; 86(16):6367-71. PubMed ID: 2474833
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IL-4 Downregulates IL-1β and IL-6 and Induces GATA3 in Psoriatic Epidermal Cells: Route of Action of a Th2 Cytokine.
    Onderdijk AJ; Baerveldt EM; Kurek D; Kant M; Florencia EF; Debets R; Prens EP
    J Immunol; 2015 Aug; 195(4):1744-52. PubMed ID: 26170379
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukin-1: a key inflammatory mediator in psoriasis?
    Mee JB; Cork MJ; di Giovine FS; Duff GW; Groves RW
    Cytokine; 2006 Jan; 33(2):72-8. PubMed ID: 16460958
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.